| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/17/2004 | EP1242105B1 Combination of ginseng and ginkgo to improve cognitive skills |
| 03/17/2004 | EP1225174B1 Anhydrous mirtazapine crystals and process for the production thereof |
| 03/17/2004 | EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 03/17/2004 | EP1176871A4 Novel beta-secretase and modulation of beta-secretase activity |
| 03/17/2004 | EP1146865B9 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 03/17/2004 | EP1144413B1 2,5-diazabicyclo 2.2.1]heptane derivatives, their preparation and therapeutic uses |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1091946B1 New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 03/17/2004 | EP1071684B1 IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS |
| 03/17/2004 | EP1021183B1 A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST |
| 03/17/2004 | EP1008594B1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483030A Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for the treatment of nervous system disorders |
| 03/17/2004 | CN1483029A Sodium channel modulators derived from 2-piperidylimidazoles |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483025A Chemical compounds |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1482918A Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 03/17/2004 | CN1482917A New therapeutic uses of smr1 peptides |
| 03/17/2004 | CN1482864A Composition and method |
| 03/17/2004 | CN1481884A Skin-infiltrating film of Chinese traditional medicine for curing paralysis resulting from central nerve trauma and its preparation method |
| 03/17/2004 | CN1481820A Intestine-resolved capsule of snake toxin extract for bloodvessel-related senility dementia |
| 03/17/2004 | CN1481808A Efficacious parts compositions for prevention and cure of senile dementia and preparation method |
| 03/17/2004 | CN1481802A Tetracycline medication for prevention and cure of nerve trauma disease and deafness of infants |
| 03/17/2004 | CN1481801A Tetracycline medication for prevention and cure of parkinsons and NO-related nerve retrogressive disease |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/17/2004 | CN1142141C Ethanesulfonyl-piperidine derivatives |
| 03/17/2004 | CN1141946C Wind and cold dispelling traditional chinese medicine for treating facial palsy and its preparation method |
| 03/17/2004 | CN1141941C Application of oligose mixture in treating stress brain injury |
| 03/17/2004 | CN1141937C Pharmaceutical composition containing tramadol for preparing medicine of curing hemicrania and the like |
| 03/17/2004 | CN1141936C Usage of aryl-cyclohexylamine derivative in anti-disorder of central nervous system |
| 03/16/2004 | US6706878 Spiroazabicyclic heterocyclic compounds |
| 03/16/2004 | US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706747 Treating elevated intraocular pressure, depression, non insulin-dependent diabetes, male impotence and obesity which is alleviated by treatment with an alpha 2 blocking agent |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706741 Acetylcholinesterase inhibitors containing 1-benzyl-pyridinium salts |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706727 ethyl-4-chloro- or 4-hydroxy- Ascomycin derivatives; pimecrolimus homologues; cultivating Streptomyces hygroscopius to produce the 4-hydroxy derivative; replacement of the hydroxy with chloro under epimerization; antiinflammatory; immunosupression |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/16/2004 | US6706685 Compounds and methods for stimulating β-catenin mediated gene expression and differentiation |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706293 Pharmaceutical composition capable of regulating the expression of adhesion molecules |
| 03/16/2004 | US6706289 Methods and compositions for enhanced delivery of bioactive molecules |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 03/11/2004 | WO2004020623A2 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers |
| 03/11/2004 | WO2004020442A1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 03/11/2004 | WO2004020437A1 S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020422A1 1, 4- substituted piperidine derivatives and use thereof as base-inhibitors in treatment of alzheimer's disease |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2004020411A1 Naphthamide derivatives and their use |
| 03/11/2004 | WO2004020402A1 Sulphonylamino derivatives for the treatment of alzheimer's disease |
| 03/11/2004 | WO2004020189A1 Embossable and writable multilaminate backing construction |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019987A1 Adhesive patch |
| 03/11/2004 | WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent |
| 03/11/2004 | WO2004019960A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019948A1 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-d]pyrimidine |
| 03/11/2004 | WO2004019947A1 Alpha-7 nicotinic receptor agonists and statins in combination |
| 03/11/2004 | WO2004019943A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2004019868A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2004004699A3 Use of dantrolene, a ryanodine antagonist, in treating neural injury |
| 03/11/2004 | WO2004002462A3 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 03/11/2004 | WO2004000219A3 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof |
| 03/11/2004 | WO2003106380A3 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/11/2004 | WO2003104192A3 Controlled release formulation of lamotrigine |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003095607A3 Role of p62 in aging-related disease |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003084520A3 Pharmaceutical preparation containing oxycodone and naloxone |
| 03/11/2004 | WO2003084504A3 Matrix for sustained, invariant and independent release of active compounds |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003059394A3 Composition for transporting oligonucleotides through the blood brain barrier and their use for treating central nervous system diseases |
| 03/11/2004 | WO2003059386A3 Prion protein carrier-conjugates |
| 03/11/2004 | WO2003059323A3 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003033535A3 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003015690B1 Method for treating primary insomnia |